1007581-62-5
中文名稱
1007581-62-5
英文名稱
Benzonitrile, 4-[2-(4,4-dimethyl-2-oxo-3-oxazolidinyl)-4-thiazolyl]-
CAS
1007581-62-5
分子式
C15H13N3O2S
分子量
299.35
MOL 文件
1007581-62-5.mol
1007581-62-5 結(jié)構(gòu)式
基本信息
中文別名
CANCER-TARGETING COMPOUND 1 英文別名
Cancer-Targeting Compound 1Benzonitrile, 4-[2-(4,4-dimethyl-2-oxo-3-oxazolidinyl)-4-thiazolyl]-
物理化學(xué)性質(zhì)
沸點(diǎn)465.9±47.0 °C(Predicted)
密度1.38±0.1 g/cm3(Predicted)
儲(chǔ)存條件-20°C儲(chǔ)存
溶解度溶于二甲基亞砜
酸度系數(shù)(pKa)1.72±0.50(Predicted)
形態(tài)Solid
顏色White to off-white
1007581-62-5價(jià)格(試劑級(jí))
| 報(bào)價(jià)日期 | 產(chǎn)品編號(hào) | 產(chǎn)品名稱 | CAS號(hào) | 包裝 | 價(jià)格 |
| 2026/06/05 | HY-U00300 | 1007581-62-5 Cancer-Targeting Compound 1 | 1007581-62-5 | 1mg | 5500元 |
常見(jiàn)問(wèn)題列表
生物活性
Cancer-Targeting Compound 1 可用于與激素相關(guān)的癌癥研究，摘自專利 WO 2008021331 A2。體外研究
Cancer-Targeting Compound 1 is useful for the research of hormone-related conditions including contraception, treating or preventing fibroids, endometriosis, dysfunctional bleeding, uterine leiomyomata, polycystic ovary syndrome, or hormone-dependent carcinomas, providing hormone replacement therapy, stimulating food intake or synchronizing estrus.